Skip to main content
. Author manuscript; available in PMC: 2017 Aug 1.
Published in final edited form as: Oral Oncol. 2016 Aug;59:12–19. doi: 10.1016/j.oraloncology.2016.05.007

Table 2.

HSC3 cell cycle analysis.

Treatment SubG1 G1 S G2
Control 0.84 85.67 8.21 4.91
Gefitinib 2.03 95.60 0.0 1.87
TAE684 0.34 95.23 0.84 3.73
Combination 1.90 96.25 0.59 2.26

Values represent % of cell distribution.